Yang Laboratory

Currently, the Yang Laboratory is applying quantitative and functional proteomics approaches to tackle two grand challenges in the field of cancer proteomics: identifying novel cancer biomarkers and decoding cancer cell signaling networks. These studies will lead to the discovery of novel biomarkers and drug targets for personalized cancer detection, diagnosis, and treatment.

The Yang Laboratory is affiliated with the Samuel Oschin Comprehensive Cancer Institute, Surgery Department and Department of Biomedical Sciences.


Android app on Google Play